We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Wearable Technology Combined with AI Algorithms Offers More Accurate Way to Diagnose Parkinson’s

By HospiMedica International staff writers
Posted on 24 Sep 2024
Print article
Image: Wearable sensors and machine learning system could pinpoint Parkinson’s (Photo courtesy of 123RF)
Image: Wearable sensors and machine learning system could pinpoint Parkinson’s (Photo courtesy of 123RF)

Parkinson's disease typically begins with mild symptoms, like a slight tremor in one hand, but can progress to more severe conditions such as muscle stiffness and difficulty walking without assistance. Diagnosing this debilitating movement disorder, particularly in its early stages, usually requires patients to perform various mobility tasks, with clinicians observing walking patterns and testing reflexes. This process is time-consuming and labor-intensive for both doctors and patients. Experts believe many individuals remain undiagnosed or are misdiagnosed, indicating that more people may have the disease than current estimates suggest. This highlights one of the primary challenges faced by clinicians and patients: the difficulty in accurately diagnosing Parkinson's disease. A more accurate diagnostic method could alleviate the physical and emotional strain patients experience by reducing the need for multiple clinic visits and preventing misdiagnoses.

Researchers at the University of Maryland, College Park’s Center for Bioinformatics and Computational Biology (CBCB, College Park, MD, USA) are collaborating with colleagues to address this issue using machine learning algorithms to analyze data from wearable movement-tracking sensors, aiming to automate parts of the diagnostic process. According to the researchers, this approach could lead to earlier and more accurate diagnoses, enabling timely therapeutic interventions. While wearable sensors for diagnosing Parkinson’s disease have been developed in the past, their complexity has hindered widespread clinical adoption. This new research simplifies the use of sensors and machine learning in clinical settings. The study demonstrated that a single sensor placed on the lower back, combined with a single mobility task involving multiple movements, could effectively differentiate individuals with Parkinson’s disease from healthy controls.

The research team then created an advanced machine-learning framework to analyze patterns and variations in the collected data. As detailed in the journal Sensors, this approach significantly improved the detection of disease symptoms and diagnostic accuracy, achieving an accuracy rate of 92.6% in identifying participants across various stages of Parkinson’s disease—surpassing the 81% accuracy previously reported for clinical diagnoses by movement disorder experts. The team is now expanding its research to distinguish Parkinson’s from other movement disorders, aiming to further increase diagnostic accuracy and reduce the likelihood of misdiagnosis.

Related Links:
CBCB

Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Vital Signs Monitor
Vista 120 SC
New
Endocavity Needle Guide
Vitro PRO

Print article

Channels

Surgical Techniques

view channel
Image: Molecular imaging of the adrenal glands in three patients (Photo courtesy of QMUL)

Endoscopic Ultrasound-Guided Procedure Could Transform Blood Pressure Management

Primary aldosteronism (PA) is a hormonal disorder that causes high blood pressure in approximately one in 20 patients with hypertension but often goes undiagnosed and untreated. In this condition, benign... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.